- Δεν υπάρχουν δεδομένα
Ελληνικά
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Background IntroductionTwo dimensional materials have attracted widespread attention due to their atomic level thickness and unique properties, such as high binding energy, tunable bandgap, and new electronic degrees of freedom (valley electronics). They have many application prospects in fields such as microelectronics, nanophotonics, and nanoenergy. Various two-dimensional materials have their o...
Ultra short laser pulses for local welding (Source: Fraunhofer IOF)With the accelerated evolution of electronic devices towards high power, high frequency, and miniaturization, ceramic substrates have become core materials in fields such as power semiconductors, 5G communications, and new energy vehicles due to their excellent thermal conductivity, insulation, and high temperature resistance. H...
Recently, teachers and students from the Institute of Solid State Laser and Ultrafast Photonics at the School of Physics and Optoelectronic Engineering have made significant progress in the study of ultrafast carrier dynamics in optoelectronic functional crystals. The related research results are titled "Anisotropic carrier dynamics and laser fabricated luminosity patterns on oriented single cryst...
Recently, Confluence Networks LLC has announced a long-term partnership agreement with Laser Light Communications Inc., a developer and provider of software controlled optical network services.According to the agreement, Laser Light will adopt Confluence-1 submarine fiber optic network, which Confluence Networks is about to launch, as the core part of its global network. The protocol will last for...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...